Program
Timetable
Brief Program (English sessions only)
Special Lecture【Room 1】Saturday, March 1, 2025, 10:10～11:10
～The Cutting Edge of PTCy-based HCT in the World～
- Chair
- Hirohisa Nakamae
- （Department of Hematology, Osaka Metropolitan University Graduate School of
Medicine）
The Cutting Edge of PTCy-Based Transplant in the World
- Presenters
- Christopher Kanakry
- （Center for Immuno-Oncology, National Institutes of Health, USA）
The Current Status and Future of Hematopoietic Cell Transplantation with
Post-Transplantation Cyclophosphamide
- Shannon R. McCurdy
- （University of Pennsylvania, Perelman School of Medicine, USA）
Symposium
Symposium 2【Room 5】Friday, February 28,
2025, 8:40～10:40
Treatment Practices of CAR-T and Bispecific Antibodies
- Chair
- Satoshi Yoshihara
- （Department of Respiratory Medicine and Hematology, Hyogo Medical
University）
- Dai Maruyama
- （Department of Hematology Oncology, Cancer Institute Hospital, Japanese
Foundation for Cancer Research）
Optimal use and Indications of CAR-T Therapy and the Role of Allogeneic
HSCT in Multiple Myeloma
- Presenters
- Taku Kikuchi
- （Department of Hematology, Japanese Red Cross Medical Center）
CAR T-cell therapy for B-cell non-Hodgkin lymphoma: Eligibility and
toxicity management
- Shinichi Makita
- （Department of Hematology, National Cancer Center Hospital）
Positioning of Allo-SCT and BsAbs in Relapse After CAR-T Therapy
- María-Victoria Mateos
- （University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC
(USAL-CSIC), Spain）
Evolving CAR T Therapy: Insights from Real-World Clinical Experience
- Yi Lin
- （Cancer Regenerative Biotherapeutics, Mayo Clinic Comprehensive Cancer
Center, Mayo Clinic, USA）
JSTCT-KSBMT Joint Symposium【Room 10】Friday, February 28, 2025,
15:15～16:45
Endothelial Damage Syndrome
- Chair
- Ho Joon Im
- （Department of Pediatrics, Asan Medical Center, University of Ulsan College
of Medicine, Korea）
- Takanori Teshima
- （Department of Hematology, Hokkaido University Faculty of Medicine, Japan）
Current perspectives of hepatic VOD/SOS after allogeneic hematopoietic
cell transplantation; Korean real-world experience of defibrotide for severe hepatic VOD/SOS
- Presenters
- Jae-Ho Yoon
- （Catholic University of Korea Internal medicine VOD/SOS／International
cooperative committee of KSBMT, Korea）
Transplant-Associated TMA: Current Clinical Experience and Emerging
Insights
- Kyung-Nam Koh
- （Department of Pediatrics, Asan Medical Center Children's Hospital,
University of Ulsan College of Medicine, Korea）
Advancing Early Diagnosis and Intervention in Sinusoidal Obstruction
Syndrome/Veno-occlusive Disease
- Kimikazu Yakushijin
- （Department of Medical Oncology and Hematology, Kobe University Hospital,
Japan）
Complement involvements and issues in TA-TMA after allogeneic
hematopoietic cell transplantation
- Yusuke Okayama
- （Department of Hematology, Osaka Metropolitan University Graduate School of
Medicine / Department of Hematology, Wakakusa-Daiichi Hospital, Japan）
Luncheon Seminar
Luncheon Seminar 4【Room 5】Friday, February 28, 2025, 12:00～12:50
Evolving CAR T Therapy -Insights from Real-World Clinical Experience-
- Chair
- Koji Kato
- （Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences）
- Yi Lin, M.D., Ph.D.
- （Enterprise Deputy Director, Cancer Regenerative Biotherapeutics, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic）
Luncheon Seminar 15【Room 1】Saturday, March 1, 2025, 11:30～12:20
Improved HCT outcomes: advances in acute GVHD diagnosis and treatment
- Chair
- Takanori Teshima
- （Hokkaido University）
- James L.M. Ferrara
- （Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai）
Sponsored Symposium
Sponsored Symposium 2【Room 12】Friday, February 28, 2025, 13:05～14:35
Treatment Strategies for Multiple Myeloma with Novel Agents
- Chair
- Satoshi Yoshihara
- （Department of Respiratory Medicine and Hematology , Hyogo Medical University）
- Kazutaka Sunami
- （Department of Hematology , NHO Okayama Medical Center）
Teclistamab covering an unmet need in myeloma
- María-Victoria Mateos, MD, PhD
- （Head of Unit at the hematology Department, Salamanca University, Spain）
Treatment strategy for TCE RRMM in Japan
- Tadao Ishida
- （Department of Hematology / Myeloma-Amyloidosis Center , Japanese Red Cross Medical Center）
